|
|
2007-05-30 - Cedara Agreement
CEDARA SOFTWARE ANNOUNCES AGREEMENT WITH BIOTRONICS 3D ON NEW C4 CLINICAL PLUG-IN MODULES London, UK, May 30, 2007 – Cedara Software, a Merge Healthcare company (NASDAQ: MRGE; TSX: MRG) and a leading independent developer of medical software technologies for the global healthcare market, announced an agreement with Biotronics3D, Ltd., that grants the London-based software company a license to market C4 enabled versions of its 3Dnet Suite family of 3D visualization software*. Under the agreement, Biotronics3D will distribute C4 enabled Biotronics3D applications to the growing number of OEMs that are adopting the C4 framework and other C4 clinical application modules from Cedara and its other partners. The C4 ( Cedara Clinical Control Center) platform is a software framework that enables a host application to obtain plug-and-play access to a diverse array of clinical application modules after completing a one-time integration. C4 enabled plug-in modules can be launched from any C4 enabled host, a PACS or clinical workstation for example. The growing portfolio of C4 enabled plug-in modules now includes three Biotronics3D applications (3D Virtual Colonoscopy, 3D General Diagnostic and 3D angiography*) and Cedara’s own C4 enabled applications, including I-ReadMammo** (mammography), PET/CT** and OrthoWorks Pro Planner (orthopaedics). "I believe the addition of the 3Dnet Suite to the growing portfolio of Cedara C4 enabled applications gives OEM suppliers of PACS workstations a convenient way to offer to healthcare providers many clinical applications that are in high demand," said Haralambos Hatzakis, CEO of Biotronics3D. "The synergies between Cedara and Biotronics3D solutions based on the C4 integration platform will help clinicians improve workflow and could help contribute to diagnostic accuracy in CT, MRI and PET studies. "We selected Biotronics3D to be a key partner based on the obvious synergies that our solutions possess together," said Loris Sartor, president of Cedara Software. "With this agreement, Cedara significantly strengthens its portfolio of clinical solutions that we can offer customers that use C4 enabled products." C4 enabled 3D Virtual Colonoscopy, 3D Angiography and 3D General Diagnostic modules The Biotronics3D 3Dnet product suite is a protocol-driven set of tools that permits clinicians to intuitively visualize the patient’s MRI, CT and PET studies in 3D on a standard Windows-based PC. 3Dnet can be integrated with a hospital’s or imaging center’s PACS or RIS/PACS to provide a seamless experience for clinicians. In addition, because 3Dnet™ applications do not require any proprietary or specialized hardware to operate, they may be deployed throughout the healthcare enterprise at relatively low cost. About C4 Biotronics3D, headquartered in London, England, develops and markets innovative software applications for the diagnostic imaging industry. With an objective of transforming the way that healthcare providers interact with 3D images, Biotronics3D provides cutting edge software technologies to improve healthcare by better extracting diagnostic data and transforming it into usable information available at the point-of-care. Additional information about Biotronics3D may be found at www.biotronics3d.com. Cedara Software is a Merge Healthcare company focused on the development of customized software solutions and development tools for the medical imaging OEM market. Cedara’s solutions enable OEM companies to accelerate their time-to-market, reduce development costs and access new streams of revenue. Cedara’s software is deployed in hospitals and clinics worldwide and is licensed by many of the world's LEADING medical device AND healthcare information technology companies. Cedara’s technologies AND engineering services span ALL the major digital imaging modalities AND a wide variety OF clinical specialties including radiology, orthopaedics, women’s health, oncology, cardiac imaging, clinical trials, imaging FOR the veterinarian market AND MORE. FOR additional information, visit our website AT www.cedara.com. Healthcare. |
 |